Health
Study Finds Stark Global Inequalities in Cost of Essential Medicines
European countries are spending more on essential medicines than any other region, but wealthier nations ultimately benefit from greater affordability once purchasing power is taken into account, a new international study has found.
The research, published in the JAMA Health Forum, analyzed the cost and availability of 549 essential medicines across 72 markets worldwide. These drugs, drawn from the World Health Organization’s (WHO) list of essential medicines, range from painkillers and antibiotics to anesthetics, chemotherapy drugs, and treatments for mental health conditions.
The study revealed that in 2022, European nations collectively spent around €1.74 billion, averaging €167 per person. In comparison, the Americas spent approximately €868 million overall, while Southeast Asia reported just €6 per capita. Availability of medicines also varied widely, with Germany stocking 438 of the listed medicines, compared with just 225 in Kuwait. Across 33 European countries included, the average was 367 medicines available.
While richer nations typically face higher list prices for drugs, they are cushioned by stronger purchasing power, national insurance systems, and state-led price negotiations. Once these factors are taken into account, many wealthier countries enjoy some of the lowest effective medicine costs globally.
By contrast, lower-income nations, despite often showing lower list prices, face a disproportionate burden. For people in parts of Africa and Southeast Asia, a month’s treatment can cost weeks of wages, forcing families to make impossible choices between healthcare and other essentials.
The study highlighted significant variations across regions. In Lebanon, for instance, drug prices were roughly one-fifth of those in Germany when adjusted for purchasing power, while in Argentina, they were nearly six times higher. In Pakistan, the cost of medicines equaled German levels once purchasing power was considered, while in the United States, prices reached three times higher than Germany’s.
The financial burden was most acute for treatments such as chemotherapy and chronic disease medications. A minimum-wage worker in India would need about 10 days’ wages to afford a month’s supply of tenofovir disoproxil, a drug for hepatitis B and HIV/AIDS. For paclitaxel, a chemotherapy drug, workers in poorer countries could spend nearly six weeks of wages on a single month’s treatment.
Mental health and cardiovascular drugs emerged as some of the costliest categories, while hepatitis treatments were among the least expensive. Researchers stressed that these disparities highlight a pressing issue of global health equity.
“Some poorer countries face a higher burden of medication costs, even if the price for the same medicine is lower compared to richer countries,” the study concluded, urging policymakers to consider both price and affordability in shaping access to essential treatments.
Health
Global Mental Health Cases Near 1.2 Billion as Anxiety and Depression Drive Sharp Worldwide Rise
A major global analysis has found that mental health conditions have surged to an estimated 1.2 billion people worldwide, driven largely by steep increases in anxiety and depression over the past three decades.
The findings, published in The Lancet as part of the Global Burden of Disease Study 2023, show that the number of people living with mental disorders has almost doubled since 1990, marking a 95% rise. Researchers say major depressive disorder and anxiety disorders have seen even sharper growth, increasing by 131% and 158% respectively, making them the most prevalent mental health conditions globally.
The report describes mental illnesses as widespread conditions that create long-term disability and significant human suffering. It also highlights broader consequences for economies and public services, including reduced productivity, lower workforce participation and increasing pressure on health and welfare systems.
Researchers estimate that in 2023 alone, around 620 million females and 552 million males were affected by mental health conditions. While the overall burden is rising across both sexes, the study points to notable differences in the types and prevalence of disorders.
Among women, depression and anxiety were the most commonly reported conditions, alongside higher rates of eating disorders such as anorexia nervosa and bulimia nervosa. The report links this disparity to a mix of biological, social and structural factors, including exposure to domestic violence, sexual abuse, gender inequality and reproductive health-related changes.
In contrast, neurodevelopmental and behavioural disorders, including attention deficit hyperactivity disorder (ADHD), conduct disorder and autism spectrum conditions, were more frequently diagnosed in men.
Teenagers aged 15 to 19 were identified as the group experiencing the highest mental health burden globally, raising concerns about early onset of conditions and insufficient preventive care for young people.
The study identifies several key risk factors associated with mental illness, including childhood sexual violence, bullying and intimate partner violence. These factors are strongly linked to conditions such as depression, schizophrenia, bipolar disorder and anxiety disorders. However, researchers note that such exposures have remained relatively stable over time and account for only a portion of the overall rise.
According to the authors, broader drivers are likely contributing to the increasing prevalence of mental disorders. These include genetic and biological influences, poverty, inequality, and the growing impact of global crises such as armed conflict, pandemics, natural disasters and climate-related stress.
While mental health conditions have long been a leading cause of disability worldwide, the report warns that the situation is worsening. At the same time, health systems have not expanded services at a pace matching demand.
The authors caution that the gap between rising need and limited access to care is becoming more pronounced, leaving millions without adequate treatment or support.
Health
Europe Records Sharp Rise in Sexually Transmitted Infections, ECDC Warns
Health
White House Rejects Report It Blocked Return of Ebola-Infected US Doctor
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
